|Item||Catalog #||Description||Quantity||Price (USD)|
|Plasmid||141385||Standard format: Plasmid sent in bacteria as agar stab||1||$75 *|
|Lentiviral Prep||141385-LV||Virus (1mL at titer ≥ 5x10⁶ TU/mL) and Plasmid.|
* Login to view industry pricing.
Backbone manufacturerTakara Bio
- Backbone size w/o insert (bp) 8825
Vector typeMammalian Expression, Lentiviral
Growth in Bacteria
Growth Strain(s)NEB Stable
Mutationhuman codon optimized
Entrez GeneE (a.k.a. GU280_gp04)
- Promoter EF1alpha
/ Fusion Protein
- 2xStrep (C terminal on insert)
- Cloning method Unknown
Terms and Licenses
Information for Lentiviral Prep (Catalog # 141385-LV) ( Back to top )
Ready-to-use Lentiviral Prep particles produced from pLVX-EF1alpha-SARS-CoV-2-E-2xStrep-IRES-Puro (#141385). In addition to the viral particles, you will also receive purified pLVX-EF1alpha-SARS-CoV-2-E-2xStrep-IRES-Puro plasmid DNA.Lentiviral particles carrying SARS-CoV-2-E. This virus is used to make stable cell lines expressing the SARS-CoV-E protein.
- Volume 1mL
- Titer ≥ 5x10⁶ TU/mL
- Pricing $100 USD for preparation of 1mL virus + $30 USD for plasmid.
- Storage Store at -80℃. Thaw just before use and keep on ice.
- Shipment Viral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
Requestor is responsible for compliance with their institution's biosafety regulations. Lentivirus is generally considered BSL-2. AAV is generally considered BSL-1, but may require BSL-2 handling depending on the insert. Biosafety Guide
Terms and Licenses
- Not Available to Industry
Viral Quality Control
- ddPCR assay: 293T cells were transduced with serial dilutions of 141385-LV, harvested several days later, and genomic DNA was isolated. Copies of RRE were measured and normalized to RPP30.
- PCR confirmation of insert: PCR was carried out on the viral preparation with primers targeting the pLenti backbone and the insert. The PCR product was visualized on an agarose gel for size confirmation.
Visit our viral production page for more information.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
For your Materials & Methods section:pLVX-EF1alpha-SARS-CoV-2-E-2xStrep-IRES-Puro was a gift from Nevan Krogan (Addgene plasmid # 141385 ; http://n2t.net/addgene:141385 ; RRID:Addgene_141385)
For viral preps, please replace (Addgene plasmid # 141385) in the above sentence with: (Addgene viral prep # 141385-LV)
For your References section:A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug Repurposing. Gordon DE, et al.. BioRxiv March 2020 10.1101/2020.03.22.002386